EKF Diagnostics Showcases Range of Diabetes and Hematology POC Devices
|
By LabMedica International staff writers Posted on 01 Aug 2024 |
|
EKF Diagnostics (Cardiff, Wales, UK) is showcasing its range of diabetes and hematology point-of-care (POC) devices and connectivity software at ADLM 2024.
Among its diabetes POC devices, EKF is highlighting the Quo-Lab HbA1c semi-automated desktop POC analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use. EKF is also showcasing the Quo-Test fully automated desktop POC analyzer designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a POC setting such as diabetes clinics and doctors’ surgeries. This fully automated hemoglobin A1c analyzer uses patented boronate affinity fluorescence quenching technology to measure glycated hemoglobin from a 4 μl sample taken from a capillary or venous whole blood. Also featuring at the show is the STAT-Site WB analyzer for the quantitative determination of β-ketones (Beta-Hydroxybutyrate or β-HB) and glucose in whole blood taken from capillary or venous samples.
Additionally, EKF is presenting its newly launched Biosen C-Line, an advanced version of its industry-leading rapid benchtop glucose and lactate analyzer. The new and updated analyzer has been designed to enhance usability with the latest color, touch screen, and advanced connectivity, enabling the Biosen C-Line to seamlessly connect with hospital and laboratory IT systems, via EKF Link, to ensure patient results are quickly and securely available to clinicians. Visitors to the EKF booth at the show can also experience the EKF Link middleware solution for healthcare providers that is designed to manage their POC analyzers and the generated data on one centralized platform. EKF Link is a flexible, open solution that can be interfaced with most vendors’ POC analyzers to permit the real-time management of data including patient test results, QC results, operator management, and analyzer configuration.
Within its portfolio of hematology POC devices, EKF is highlighting the DiaSpect Tm hand-held hemoglobin analyzer which is now powered by EKF Link, enabling new functions like hematocrit calculation, quality control management, and patient data management functions. The proven technology of DiaSpect Tm delivers laboratory-quality results in one second from the microcuvette being placed into the analyzer. In addition, EKF is featuring the Hemo Control POC hemoglobin analyzer which is designed to provide quantitative, lab-quality hemoglobin results in 25 seconds. Also featuring at the show is the HemataStat II microhematocrit centrifuge that provides a quantitative hematocrit reading for up to six blood samples from one 60-second spin.
Related Links:
EKF Diagnostics
Latest ADLM 2024 News
- HemoSonics Demonstrates Breakthrough in Point-Of-Care Viscoelastic Hemostasis Testing
- Cytovale Demonstrates 8-Minute Sepsis Diagnostic Test
- Inpeco Launches Next-Generation Total Lab Automation System
- Messe Düsseldorf Promotes International “MEDICAlliance” Portfolio at ADLM 2024
- Tianlong Showcases Latest Products in Molecular Diagnostics, Biochemistry, Immunology and POC Testing
- QuidelOrtho Demonstrates Advanced Diagnostic Laboratory Solutions across Healthcare Continuum
- HORIBA Unveils New Compact Hematology Analyzers with Combined ESR and CBC/Diff
- Beckman Coulter Introduces Latest Innovations in Clinical Diagnostics
- Abbott Demonstrates End to End Laboratory Solutions
- Werfen Introduces GEM Premier 7000 with iQM3 Blood Gas Testing System
- Thermo Fisher Showcases Diagnostics Innovation Across Therapeutic Areas
- Siemens Demonstrates Human-Centered Engineering and Automation for Laboratory Testing
- Roche Showcases Solutions for Laboratories of the Future
- POC Electrical Sensing-Based Blood Testing Technology Unveiled at ADLM 2024
- World's First 5-Minute Real-Time PCR Instrument Debuts at ADLM 2024
- ADLM 2024 Showcases Breakthrough Innovations Shaping Future of Clinical Testing
Channels
Clinical Chemistry
view channel
Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
Hepatitis B virus (HBV) continues to pose a significant global health challenge, with chronic infection affecting hundreds of millions of people despite effective vaccines and antiviral therapies.... Read more
Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
Multiple myeloma is an incurable cancer of the bone marrow, and while many patients now live for more than a decade after diagnosis, a significant proportion relapse much earlier with poor outcomes.... Read more
Molecular Diagnostics
view channel
Blood Test Promises Faster Answers for Deadly Fungal Infections
Invasive mold infections caused by filamentous fungi are among the most challenging fungal diseases to diagnose, as the organisms grow slowly and often take days to weeks to culture. Current diagnostic... Read more
AI Algorithm Predicts Cancer Metastasis and Recurrence Risk
Some tumors spread to distant organs while others remain localized, making it one of the most critical unanswered questions in cancer care. Metastasis is the leading cause of death in most cancers, yet... Read more
Blood Test Could Detect Molecular Barcodes Capable of Distinguishing Cancer Types
Some cancers are difficult to classify, track, and monitor after treatment, posing a major clinical challenge. Many tumors shed little DNA into the bloodstream, making it hard to detect minimal residual... Read more
Blood Test Could Enable Earlier Detection of Liver Cancer Recurrence After Transplant
Liver cancer is a leading cause of cancer deaths worldwide, with more than 800,000 diagnoses and over 700,000 deaths each year. Disease recurrence after liver transplantation is common and is associated... Read moreHematology
view channel
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read more
Immunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read more
Pathology
view channel
New X-Ray Method Promises Advances in Histology
Histological tissue analysis is a cornerstone of medical diagnostics, allowing doctors to identify tumors and other pathological changes using stained tissue slices viewed under a microscope.... Read more
Single-Cell Profiling Technique Could Guide Early Cancer Detection
Cancer often develops silently over many years, as individual cells acquire mutations that give them a growth advantage long before a tumor forms. These pre-malignant cells can exist alongside normal cells... Read more
Technology
view channel
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read more
Industry
view channel
WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
World Health Expo (WHX) Labs in Dubai (formerly Medlab Middle East), which will be held at Dubai World Trade Centre from 10-13 February, will address the growing global threat of antimicrobial resistance... Read more
